Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5
September 13, 2023
Moderna Entered into a Research and Development Collaboration with Immatics to Develop Innovative Oncology Therapies
September 11, 2023
Moderna and Merck’s mRNA-4157/V940 + Keytruda Receives PRIME Scheme Designation by the EMA for Adjuvant Treatment of High-Risk Sta...
April 7, 2023
PharmaShots' Key Highlights of First Quarter 2023
April 3, 2023
Moderna and Merck Receive the US FDA’s Breakthrough Therapy Designation for mRNA-4157/V940 + Keytruda (pembrolizumab) to Treat Hig...
February 23, 2023
Moderna Entered into a Collaboration and License Agreement with Cytomx to Develop mRNA-Based Conditionally Activated Therapies
January 9, 2023
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.